RC
FBIO icon

RBF Capital’s Fortress Biotech FBIO Stock Holding History

RBF Capital’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,000
Closed -$26K – 551
2022
Q3 		$26K Hold
2,000
– – ﹤0.01% 524
2022
Q2 		$25K Buy
+2,000
New +$29.6K ﹤0.01% 522

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $72.2B AUM 27.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RBF Capital's FBIO Position: Q4 2022 in Review

RBF Capital sold out of Fortress Biotech (FBIO) in Q4 2022, closing a stake of 2,000 shares — an estimated $26K sold.

RBF Capital first reported a position in FBIO in Q2 2022 and held it in 2 quarters. The position peaked at $26K in Q3 2022. 49 funds tracked by Wall St. Rank hold FBIO as of Q4 2022.

  • RBF Capital reported no remaining Fortress Biotech position as of Q4 2022 after selling out during the quarter.
  • RBF Capital sold 2,000 Fortress Biotech shares in Q4 2022, an estimated $26K.
  • RBF Capital first reported a position in Fortress Biotech in Q2 2022 and held it in 2 quarters.
  • RBF Capital's Fortress Biotech position peaked at $26K in Q3 2022.
  • 49 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2022.

Based on RBF Capital's 13F filing for Q4 2022, filed 14 Feb 2023.